Duopharma Biotech Bhd
KLSE:DPHARMA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Duopharma Biotech Bhd
Accounts Receivables
Duopharma Biotech Bhd
Accounts Receivables Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Accounts Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
D
|
Duopharma Biotech Bhd
KLSE:DPHARMA
|
Accounts Receivables
223.8m
|
CAGR 3-Years
15%
|
CAGR 5-Years
9%
|
CAGR 10-Years
8%
|
|
|
P
|
PeterLabs Holdings Bhd
KLSE:PLABS
|
Accounts Receivables
19.3m
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-1%
|
|
|
A
|
Apex Healthcare Bhd
KLSE:AHEALTH
|
Accounts Receivables
202.6m
|
CAGR 3-Years
3%
|
CAGR 5-Years
8%
|
CAGR 10-Years
5%
|
|
|
R
|
Rhone Ma Holdings Bhd
KLSE:RHONEMA
|
Accounts Receivables
42.3m
|
CAGR 3-Years
4%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
|
|
Y
|
YSP Southeast Asia Holding Bhd
KLSE:YSPSAH
|
Accounts Receivables
65.5m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
1%
|
CAGR 10-Years
2%
|
|
|
K
|
Kotra Industries Bhd
KLSE:KOTRA
|
Accounts Receivables
39m
|
CAGR 3-Years
1%
|
CAGR 5-Years
8%
|
CAGR 10-Years
1%
|
|
Duopharma Biotech Bhd
Glance View
Duopharma Biotech Bhd.is an investment holding company, which engages in the manufacturing and distribution of pharmaceutical products. The company is headquartered in Klang, Selangor. The company went IPO on 2002-07-18. The Company, through its subsidiaries is engaged in manufacturing, distribution, importing and exporting of pharmaceutical products and medicines. The firm also engaged in research and development of pharmaceutical products. Its subsidiaries include Duopharma (M) Sendirian Berhad, Duopharma Manufacturing (Bangi) Sdn. Bhd., Duopharma Marketing Sdn. Bhd., Duopharma Consumer Healthcare Sdn. Bhd., Duopharma HAPI Sdn. Bhd., Duopharma Innovation Sdn. Bhd., Unique Pharmacy (Penang) Sdn. Bhd., Sentosa Pharmacy Sdn. Bhd., Duopharma Manufacturing (Glenmarie) Sdn. Bhd., Negeri Pharmacy Sdn. Bhd., Duopharma (Singapore) Pte. Ltd. and DB (Philippines), Inc.
See Also
What is Duopharma Biotech Bhd's Accounts Receivables?
Accounts Receivables
223.8m
MYR
Based on the financial report for Dec 31, 2025, Duopharma Biotech Bhd's Accounts Receivables amounts to 223.8m MYR.
What is Duopharma Biotech Bhd's Accounts Receivables growth rate?
Accounts Receivables CAGR 10Y
8%
Over the last year, the Accounts Receivables growth was 15%. The average annual Accounts Receivables growth rates for Duopharma Biotech Bhd have been 15% over the past three years , 9% over the past five years , and 8% over the past ten years .
